Credit Suisse’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $972K | Buy |
51,918
+508
| +1% | +$9.51K | ﹤0.01% | 2281 |
|
|
2023
Q4 | $1.16M | Sell |
51,410
-3,432
| -6% | -$77.7K | ﹤0.01% | 2235 |
|
|
2023
Q3 | $1.36M | Sell |
54,842
-1,646
| -3% | -$40.8K | ﹤0.01% | 2074 |
|
|
2023
Q2 | $1.59M | Buy |
56,488
+8,740
| +18% | +$245K | ﹤0.01% | 2069 |
|
|
2023
Q1 | $1.07M | Buy |
47,748
+2,925
| +7% | +$65.3K | ﹤0.01% | 2274 |
|
|
2022
Q4 | $1.19M | Buy |
44,823
+12,222
| +37% | +$325K | ﹤0.01% | 2212 |
|
|
2022
Q3 | $926K | Buy |
32,601
+4,493
| +16% | +$128K | ﹤0.01% | 2366 |
|
|
2022
Q2 | $586K | Buy |
28,108
+1,366
| +5% | +$28.5K | ﹤0.01% | 2728 |
|
|
2022
Q1 | $580K | Buy |
26,742
+1,279
| +5% | +$27.7K | ﹤0.01% | 2875 |
|
|
2021
Q4 | $707K | Buy |
+25,463
| New | +$707K | ﹤0.01% | 2814 |
|
|
2021
Q1 | – | Sell |
-15,060
| Closed | -$133K | – | 3422 |
|
|
2020
Q4 | $133K | Buy |
+15,060
| New | +$133K | ﹤0.01% | 3297 |
|
|
2020
Q2 | – | Sell |
-32,512
| Closed | -$219K | – | 3291 |
|
|
2020
Q1 | $219K | Buy |
32,512
+8,709
| +37% | +$58.7K | ﹤0.01% | 2993 |
|
|
2019
Q4 | $277K | Sell |
23,803
-6,314
| -21% | -$73.5K | ﹤0.01% | 3188 |
|
|
2019
Q3 | $311K | Buy |
30,117
+6,774
| +29% | +$70K | ﹤0.01% | 3018 |
|
|
2019
Q2 | $219K | Sell |
23,343
-7,950
| -25% | -$74.6K | ﹤0.01% | 3177 |
|
|
2019
Q1 | $221K | Buy |
31,293
+1,015
| +3% | +$7.17K | ﹤0.01% | 3142 |
|
|
2018
Q4 | $223K | Buy |
30,278
+511
| +2% | +$3.76K | ﹤0.01% | 3102 |
|
|
2018
Q3 | $260K | Sell |
29,767
-10,891
| -27% | -$95.1K | ﹤0.01% | 3105 |
|
|
2018
Q2 | $458K | Buy |
40,658
+2,173
| +6% | +$24.5K | ﹤0.01% | 3015 |
|
|
2018
Q1 | $428K | Buy |
38,485
+1,466
| +4% | +$16.3K | ﹤0.01% | 3014 |
|
|
2017
Q4 | $473K | Sell |
37,019
-14,845
| -29% | -$190K | ﹤0.01% | 2974 |
|
|
2017
Q3 | $738K | Buy |
51,864
+25,473
| +97% | +$362K | ﹤0.01% | 2836 |
|
|
2017
Q2 | $340K | Sell |
26,391
-6,061
| -19% | -$78.1K | ﹤0.01% | 3005 |
|
|
2017
Q1 | $466K | Sell |
32,452
-10,319
| -24% | -$148K | ﹤0.01% | 2969 |
|
|
2016
Q4 | $668K | Buy |
42,771
+15,851
| +59% | +$248K | ﹤0.01% | 2948 |
|
|
2016
Q3 | $317K | Sell |
26,920
-708
| -3% | -$8.34K | ﹤0.01% | 3297 |
|
|
2016
Q2 | $384K | Sell |
27,628
-8,570
| -24% | -$119K | ﹤0.01% | 3268 |
|
|
2016
Q1 | $421K | Sell |
36,198
-556
| -2% | -$6.47K | ﹤0.01% | 3048 |
|
|
2015
Q4 | $603K | Buy |
36,754
+23,030
| +168% | +$378K | ﹤0.01% | 3006 |
|
|
2015
Q3 | $187K | Sell |
13,724
-12,110
| -47% | -$165K | ﹤0.01% | 3730 |
|
|
2015
Q2 | $327K | Sell |
25,834
-1,005
| -4% | -$12.7K | ﹤0.01% | 3696 |
|
|
2015
Q1 | $318K | Buy |
26,839
+9,047
| +51% | +$107K | ﹤0.01% | 3559 |
|
|
2014
Q4 | $222K | Buy |
17,792
+6,329
| +55% | +$79K | ﹤0.01% | 3846 |
|
|
2014
Q3 | $106K | Sell |
11,463
-12,008
| -51% | -$111K | ﹤0.01% | 3886 |
|
|
2014
Q2 | $153K | Sell |
23,471
-81,104
| -78% | -$529K | ﹤0.01% | 4023 |
|
|
2014
Q1 | $844K | Buy |
104,575
+24,070
| +30% | +$194K | ﹤0.01% | 2924 |
|
|
2013
Q4 | $803K | Buy |
80,505
+58,851
| +272% | +$587K | ﹤0.01% | 3053 |
|
|
2013
Q3 | $131K | Buy |
21,654
+6,635
| +44% | +$40.1K | ﹤0.01% | 3633 |
|
|
2013
Q2 | $77K | Buy |
+15,019
| New | +$77K | ﹤0.01% | 3661 |
|